Since 2020 July, ACT Genomics and pharmaceutical care foundation cooperate on the yearly program to subsidize cancer genomic profiling for patients to find drugs. Please visit-> http://www.pcfhk.org/hk/pharmacy?id=30
Published:
Hong Kong
Author(s):
The Food and Health Bureau of the Government of the Hong Kong Special Administrative Region and universities provide solid foundation for genomic profiling, while private company can accelerate market maturity and provide solutions in short terms.
Published:
Hong Kong
Author(s):
To treat Melanoma, immunotherapy shows only half effect in Asian patients comparing to Western patients. ACT Genomics is working with KMU and NHRI to find better treatment for Asians.
Published:
Taipei
Author(s):
The genomics plan in Asia is speeding up and The Food and Health Bureau of the Government of the Hong Kong Special Administrative Region establishes Hong Kong Genomics Center to implement the plan of Hong Kong genomics research and ACT Genomics will provi
Published:
Hong Kong
Author(s):
Performing NGS cancer genomic profiling through CSF liquid biopsy can overcome tumor biopsy difficulties in brain and allows more genomic mutations to be detected for accurate therapy than blood sample.
Published:
Hong Kong
Author(s):
Cancer genomic profiling helps one 62-year-old lung cancer patient find ERBB2 amplification mostly seen in breast cancer, and his cancer was controlled after using HER2 inhibitor.
Published:
Hong Kong
Author(s):
Genomics profiling can help cancer treatment, and insurance can share the financial burden in many different ways. ACT Genomics cooperates with insurance companies, medical institutes and patient advocacy groups to provide related solutions.
Published:
Hong Kong
Author(s):
With the help of AI and big data, genomic technology has increased its efficiency and provide more options for physicians
Published:
Hong Kong
Author(s):
Regular cancer treatments may not fully cover individual cancer variants which results in inefficacy, while ACT Genomics' NGS solutions can treat cancer at gene level.
Published:
Hong Kong
Author(s):
Cancer genomic profiling can provide crucial information to improve efficacy in drug development to improve efficacy, and select patients according to biomarkers for modern clinical trials.
Published:
Hong Kong
Author(s):